ADVM - Biotech Long Shot
Biotechs are still beaten up, especially the gene therapy disrupter stocks, so continuing to buy a little bit here and a little bit here of some of these stocks.
These are lottery stocks, they have few if any marketable products, but the idea is if they do come out with a block buster, well winner winner chicken dinner!!!
Adverum is into ocular gene therapy with several therapies in the pipeline with one to be late-stage clinical study.
Reason for the buy? Well a nice insider buy trade of $2.5 million in July which can often be a sign that something is in the making, or at least they have a lot of faith in the company moving forward.
Probably buy 100 shares here, that is a small under $700 position so if it goes to zero I am not hurting, but if it becomes a 10 or better bagger that is a nice hit. I mean various investors had the company above $200 for a while, so it is not unreasonable to get that type of move.
However the chances of that are low which is why we keep our risk low.
Anyways, good luck and I will touch base soon.
These are lottery stocks, they have few if any marketable products, but the idea is if they do come out with a block buster, well winner winner chicken dinner!!!
Adverum is into ocular gene therapy with several therapies in the pipeline with one to be late-stage clinical study.
Reason for the buy? Well a nice insider buy trade of $2.5 million in July which can often be a sign that something is in the making, or at least they have a lot of faith in the company moving forward.
Probably buy 100 shares here, that is a small under $700 position so if it goes to zero I am not hurting, but if it becomes a 10 or better bagger that is a nice hit. I mean various investors had the company above $200 for a while, so it is not unreasonable to get that type of move.
However the chances of that are low which is why we keep our risk low.
Anyways, good luck and I will touch base soon.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.